Literature DB >> 23149516

Elaiomycins K and L, new azoxy antibiotics from Streptomyces sp. Tü 6399*.

Niko Manderscheid1, Soleiman E Helaly, Andreas Kulik, Jutta Wiese, Johannes F Imhoff, Hans-Peter Fiedler, Roderich D Süssmuth.   

Abstract

Elaiomycins K and L, two new azoxy-type antibiotics, were detected by HPLC-diode array screening in the culture filtrate extract of Streptomyces sp. Tü 6399. The structures were determined by high-resolution MS and 2-dimensional (1)H and (13)C correlated NMR spectroscopy including (15)N-NMR experiments and established these compounds as new members of the elaiomycin family. Both metabolites show a weak antibacterial activity against Bacillus subtilis and Staphylococcus lentus as well as against the phytophathogenic strain Xanthomonas campestris.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23149516     DOI: 10.1038/ja.2012.99

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

Review 1.  Heteroatom-Heteroatom Bond Formation in Natural Product Biosynthesis.

Authors:  Abraham J Waldman; Tai L Ng; Peng Wang; Emily P Balskus
Journal:  Chem Rev       Date:  2017-04-04       Impact factor: 60.622

2.  Pharmacological and Predicted Activities of Natural Azo Compounds.

Authors:  Valery M Dembitsky; Tatyana A Gloriozova; Vladimir V Poroikov
Journal:  Nat Prod Bioprospect       Date:  2017-01-04

3.  Anti-cancer and antimicrobial potential of five soil Streptomycetes: a metabolomics-based study.

Authors:  Nada Osama; Walid Bakeer; Mai Raslan; Hanan A Soliman; Usama Ramadan Abdelmohsen; Mohamed Sebak
Journal:  R Soc Open Sci       Date:  2022-02-09       Impact factor: 2.963

4.  New azodyrecins identified by a genome mining-directed reactivity-based screening.

Authors:  Atina Rizkiya Choirunnisa; Kuga Arima; Yo Abe; Noritaka Kagaya; Kei Kudo; Hikaru Suenaga; Junko Hashimoto; Manabu Fujie; Noriyuki Satoh; Kazuo Shin-Ya; Kenichi Matsuda; Toshiyuki Wakimoto
Journal:  Beilstein J Org Chem       Date:  2022-08-10       Impact factor: 2.544

5.  Dihydromaniwamycin E, a Heat-Shock Metabolite from Thermotolerant Streptomyces sp. JA74, Exhibiting Antiviral Activity against Influenza and SARS-CoV-2 Viruses.

Authors:  Shun Saito; Kayo Funayama; Wataru Kato; Mayu Okuda; Meiko Kawamoto; Teruhiko Matsubara; Toshinori Sato; Akihiko Sato; Satoko Otsuguro; Michihito Sasaki; Yasuko Orba; Hirofumi Sawa; Katsumi Maenaka; Kazutoshi Shindo; Masaya Imoto; Midori A Arai
Journal:  J Nat Prod       Date:  2022-10-12       Impact factor: 4.803

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.